Ke Tang

State Key Laboratory Of Bioactive Substance And Function Of Natural Medicines, Chinese Academy Of Medical Sciences And Peking Union Medical College
Beijing, 100050, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Erratum: Author correction to "Identification of the dietary supplement capsaicin as an inhibitor of Lassa virus entry" [Acta Pharmaceutica Sinica B 10 (2020) 789-798].

Erratum: Author correction to "Identification of the dietary supplement capsaicin as an inhibitor of Lassa virus entry" [Acta Pharmaceutica Sinica B 10 (2020) 789-798].

Journal: Acta pharmaceutica Sinica. B

Published: July 19, 2024

Establishment of interpretable cytotoxicity prediction models using machine learning analysis of transcriptome features.

Establishment of interpretable cytotoxicity prediction models using machine learning analysis of transcriptome features.

Journal: Acta pharmaceutica Sinica. B

Published: June 26, 2024

Nardosinone and aurantio-obtusin, two medicine food homology natural compounds, are anti-influenza agents as indicated by transcriptome signature reversion.

Nardosinone and aurantio-obtusin, two medicine food homology natural compounds, are anti-influenza agents as indicated by transcriptome signature reversion.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: June 03, 2022

Identification of Nifurtimox and Chrysin as Anti-Influenza Virus Agents by Clinical Transcriptome Signature Reversion.

Identification of Nifurtimox and Chrysin as Anti-Influenza Virus Agents by Clinical Transcriptome Signature Reversion.

Journal: International journal of molecular sciences

Published: January 14, 2022

Ecogeographical Adaptation Revisited: Morphological Variations in the Plateau Brown Frog along an Elevation Gradient on the Qinghai-Tibetan Plateau.

Ecogeographical Adaptation Revisited: Morphological Variations in the Plateau Brown Frog along an Elevation Gradient on the Qinghai-Tibetan Plateau.

Journal: Biology

Published: September 11, 2021

Corrigendum to "Delivery of oncolytic adenovirus into the nucleus of tumorigenic cells by tumor microparticles for virotherapy" [Biomaterials 89C (2016) 56-66].

Corrigendum to "Delivery of oncolytic adenovirus into the nucleus of tumorigenic cells by tumor microparticles for virotherapy" [Biomaterials 89C (2016) 56-66].

Journal: Biomaterials

Published: January 03, 2021

Erratum: Author correction to 'Establishment of pseudovirus infection mouse models for in vivo pharmacodynamics evaluation of filovirus entry inhibitors' [Acta Pharmaceutica Sinica B 8 (2018) 200-208].

Erratum: Author correction to 'Establishment of pseudovirus infection mouse models for in vivo pharmacodynamics evaluation of filovirus entry inhibitors' [Acta Pharmaceutica Sinica B 8 (2018) 200-208].

Journal: Acta pharmaceutica Sinica. B

Published: September 23, 2020

Corrigendum to "Delivery of oncolytic adenovirus into the nucleus of tumorigenic cells by tumor microparticles for virotherapy" [Biomaterials 89 (2016) 56-66].

Corrigendum to "Delivery of oncolytic adenovirus into the nucleus of tumorigenic cells by tumor microparticles for virotherapy" [Biomaterials 89 (2016) 56-66].

Journal: Biomaterials

Published: September 19, 2020

Identification of the dietary supplement capsaicin as an inhibitor of Lassa virus entry.

Identification of the dietary supplement capsaicin as an inhibitor of Lassa virus entry.

Journal: Acta pharmaceutica Sinica. B

Published: January 09, 2020

Discovery of sclareol and sclareolide as filovirus entry inhibitors.

Discovery of sclareol and sclareolide as filovirus entry inhibitors.

Journal: Journal of Asian natural products research

Published: November 19, 2019

The antifungal isavuconazole inhibits the entry of lassa virus by targeting the stable signal peptide-GP2 subunit interface of lassa virus glycoprotein.

The antifungal isavuconazole inhibits the entry of lassa virus by targeting the stable signal peptide-GP2 subunit interface of lassa virus glycoprotein.

Journal: Antiviral research

Published: November 06, 2019

Identification of a clinical compound losmapimod that blocks Lassa virus entry.

Identification of a clinical compound losmapimod that blocks Lassa virus entry.

Journal: Antiviral research

Published: December 29, 2018

Showing 1-12 of 23

Last Updated: 09/26/2026